Enza Biotech

Lund, Sweden Founded: 2012 • Age: 14 yrs Acquired By Croda
Biobased nonionic surfactants are developed for various applications.

About Enza Biotech

Enza Biotech is a Healthcare company based in Lund (Sweden) founded in 2012, and was acquired by Croda in July 2017. Biobased nonionic surfactants are developed for various applications. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Glycobiology.

Company details

Enza Biotech was founded in 2012 in Lund, Sweden, within the biotechnology sector. Biobased nonionic surfactants are developed by the company, with green surfactant technology employed to manufacture oligomeric alkyl glycosides. These products are utilized in cosmetics, personal care, and pharmaceuticals. Operations focus on sustainable chemical solutions, supporting industrial applications across these fields.

  • Headquarters Lund, Sweden
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website enzabiotech.com
  • Social LinkedIn Facebook
  • Acquired by Croda (Jul 2017)
Key Metrics
  • Latest Funding Round
    $55.01K (USD), Grant

    Oct 2015

  • Investors
    Croda

    & 1 more

  • Acquired by
    Croda

    (Jul 2017)

Funding Insights of Enza Biotech

  • Total Rounds 1
  • Last Round Grant β€” $55,006
  • First Round $55,006

    (Oct 2015)

  • Investors Count 1

All 1 funding rounds of Enza Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2015$55,006Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Enza Biotech

Enza Biotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Croda and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Diversified chemicals are manufactured by Croda in various sectors worldwide.
1925croda.comGoole, United Kingdom
Premium access

Investor details for Enza Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Enza Biotech

3 dated milestones of Enza Biotech across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Enza Biotech is founded.
  2. Funding First funding round of $55K.
  3. Exit Acquired by Croda.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Enza Biotech

Enza Biotech was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Enza Biotech is headquartered in Lund, Sweden.

Enza Biotech was founded in 2012 in Lund, Sweden, within the biotechnology sector. Biobased nonionic surfactants are developed by the company, with green surfactant technology employed to manufacture oligomeric alkyl glycosides. These products are utilized in cosmetics, personal care, and pharmaceuticals. Operations focus on sustainable chemical solutions, supporting industrial applications across these fields.

Enza Biotech has 2 investors. Key investors include Croda, and EIC Fund.

Yes. Enza Biotech was acquired by Croda in July 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available